Meta Growth Competitors

Meta Growth (CVE:META) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.

Profitability

This table compares Meta Growth and MediPharm Labs' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings for Meta Growth and MediPharm Labs, as reported by MarketBeat.com.

MediPharm Labs has a consensus target price of C$1.53, indicating a potential upside of 218.75%. Given MediPharm Labs' higher possible upside, analysts plainly believe MediPharm Labs is more favorable than Meta Growth.

Earnings & Valuation

This table compares Meta Growth and MediPharm Labs' gross revenue, earnings per share (EPS) and valuation.

Meta Growth has higher revenue and earnings than MediPharm Labs. MediPharm Labs is trading at a lower price-to-earnings ratio than Meta Growth, indicating that it is currently the more affordable of the two stocks.

Summary

Meta Growth beats MediPharm Labs on 4 of the 7 factors compared between the two stocks.

Khiron Life Sciences (CVE:KHRN) and Meta Growth (CVE:META) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability.

Earnings and Valuation

This table compares Khiron Life Sciences and Meta Growth's gross revenue, earnings per share (EPS) and valuation.

Khiron Life Sciences has higher earnings, but lower revenue than Meta Growth. Khiron Life Sciences is trading at a lower price-to-earnings ratio than Meta Growth, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations for Khiron Life Sciences and Meta Growth, as reported by MarketBeat.

Khiron Life Sciences currently has a consensus target price of C$1.20, indicating a potential upside of 140.00%. Given Khiron Life Sciences' higher probable upside, equities analysts clearly believe Khiron Life Sciences is more favorable than Meta Growth.

Profitability

This table compares Khiron Life Sciences and Meta Growth's net margins, return on equity and return on assets.

Meta Growth (CVE:META) and Delta 9 Cannabis (TSE:DN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Meta Growth and Delta 9 Cannabis' top-line revenue, earnings per share (EPS) and valuation.

Delta 9 Cannabis has lower revenue, but higher earnings than Meta Growth. Delta 9 Cannabis is trading at a lower price-to-earnings ratio than Meta Growth, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Meta Growth and Delta 9 Cannabis, as reported by MarketBeat.

Delta 9 Cannabis has a consensus target price of C$1.10, suggesting a potential upside of 89.66%. Given Delta 9 Cannabis' higher probable upside, analysts clearly believe Delta 9 Cannabis is more favorable than Meta Growth.

Profitability

This table compares Meta Growth and Delta 9 Cannabis' net margins, return on equity and return on assets.

Summary

Delta 9 Cannabis beats Meta Growth on 5 of the 7 factors compared between the two stocks.

48North Cannabis (CVE:NRTH) and Meta Growth (CVE:META) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Earnings and Valuation

This table compares 48North Cannabis and Meta Growth's revenue, earnings per share (EPS) and valuation.

Meta Growth has higher revenue and earnings than 48North Cannabis. Meta Growth is trading at a lower price-to-earnings ratio than 48North Cannabis, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares 48North Cannabis and Meta Growth's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 48North Cannabis and Meta Growth, as provided by MarketBeat.com.

Summary

Meta Growth beats 48North Cannabis on 3 of the 5 factors compared between the two stocks.

(CSI) (CNSX:CSI) and Meta Growth (CVE:META) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and target prices for (CSI) and Meta Growth, as reported by MarketBeat.

Profitability

This table compares (CSI) and Meta Growth's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares (CSI) and Meta Growth's top-line revenue, earnings per share (EPS) and valuation.

(CSI) has higher earnings, but lower revenue than Meta Growth.

Summary

Meta Growth beats (CSI) on 1 of the 1 factors compared between the two stocks.

28896 (CNSX:BAMM) and Meta Growth (CVE:META) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk.

Earnings and Valuation

This table compares 28896 and Meta Growth's revenue, earnings per share (EPS) and valuation.

28896 has higher earnings, but lower revenue than Meta Growth.

Analyst Ratings

This is a breakdown of current recommendations and price targets for 28896 and Meta Growth, as reported by MarketBeat.

Profitability

This table compares 28896 and Meta Growth's net margins, return on equity and return on assets.

Summary

Meta Growth beats 28896 on 1 of the 1 factors compared between the two stocks.